Sharon Hunt

5.8k total citations · 2 hit papers
114 papers, 4.3k citations indexed

About

Sharon Hunt is a scholar working on Hepatology, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Sharon Hunt has authored 114 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Hepatology, 48 papers in Epidemiology and 29 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Sharon Hunt's work include Hepatitis C virus research (42 papers), Liver Disease Diagnosis and Treatment (41 papers) and Atrial Fibrillation Management and Outcomes (18 papers). Sharon Hunt is often cited by papers focused on Hepatitis C virus research (42 papers), Liver Disease Diagnosis and Treatment (41 papers) and Atrial Fibrillation Management and Outcomes (18 papers). Sharon Hunt collaborates with scholars based in United States, United Kingdom and Germany. Sharon Hunt's co-authors include Linda Henry, Zobair M. Younossi, Maria Stepanova, Niv Ad, Youssef Younossi, Andrei Racila, Fatema Nader, Rachel Beckerman, Deirdre B Blissett and Robert Blissett and has published in prestigious journals such as Gastroenterology, Journal of the American College of Cardiology and Analytical Chemistry.

In The Last Decade

Sharon Hunt

114 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe

2016 916 citations Zobair M. Younossi, Linda Henry et al. profile →
Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009

2015 593 citations Zobair M. Younossi, Linda Henry et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sharon Hunt United States	32	3.0k	2.4k	669	633	438	114	4.3k
Mark Muthiah Singapore	32	2.5k 0.8×	1.2k 0.5×	1.0k 1.6×	456 0.7×	636 1.5×	184	4.1k
Yee Hui Yeo United States	27	2.0k 0.7×	1.1k 0.4×	613 0.9×	314 0.5×	416 0.9×	112	3.4k
Abdel Aziz Shaheen Canada	35	3.3k 1.1×	2.2k 0.9×	694 1.0×	281 0.4×	1.6k 3.7×	114	5.6k
Stuart McPherson United Kingdom	32	5.3k 1.8×	3.2k 1.3×	1.9k 2.8×	468 0.7×	902 2.1×	139	6.2k
A. Sidney Barritt United States	33	2.4k 0.8×	1.6k 0.7×	459 0.7×	169 0.3×	2.0k 4.7×	125	5.1k
Cheng Han Ng Singapore	35	2.1k 0.7×	1.0k 0.4×	1.0k 1.5×	529 0.8×	697 1.6×	169	4.2k
Peter Jepsen Denmark	44	4.1k 1.4×	3.5k 1.5×	516 0.8×	193 0.3×	1.7k 3.8×	185	6.1k
Nicholas Chew Singapore	31	1.2k 0.4×	431 0.2×	695 1.0×	838 1.3×	415 0.9×	207	3.1k
Biyao Zou United States	16	1.3k 0.4×	627 0.3×	559 0.8×	162 0.3×	233 0.5×	27	2.0k
Joseph J. Larson United States	35	2.3k 0.8×	1.6k 0.6×	446 0.7×	257 0.4×	1.4k 3.3×	104	4.0k

Countries citing papers authored by Sharon Hunt

Since Specialization

Citations

This map shows the geographic impact of Sharon Hunt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Hunt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Hunt more than expected).

Fields of papers citing papers by Sharon Hunt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon Hunt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Hunt. The network helps show where Sharon Hunt may publish in the future.

Co-authorship network of co-authors of Sharon Hunt

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon Hunt. A scholar is included among the top collaborators of Sharon Hunt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon Hunt. Sharon Hunt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hunt, Sharon, et al.. (2019). The Budgetary Impacts of Hospital-Acquired Infections. 31(1). 25. 2 indexed citations

Hunt, Sharon, et al.. (2018). Patient Violence against Healthcare Workers. 30(2). 127. 2 indexed citations

Younossi, Zobair M., et al.. (2017). In an era of highly effective treatment, hepatitis C screening of the United States general population should be considered. Liver International. 38(2). 258–265. 31 indexed citations

Younossi, Zobair M., Maria Stepanova, Stéfan Wirth, et al.. (2017). Quality of life in adolescents with hepatitis C treated with sofosbuvir and ribavirin. Journal of Viral Hepatitis. 25(4). 354–362. 19 indexed citations

Younossi, Zobair M., Maria Stepanova, Mark Sulkowski, et al.. (2017). Patient‐reported outcomes in patients co‐infected with hepatitis C virus and human immunodeficiency virus treated with sofosbuvir and velpatasvir: The ASTRAL‐5 study. Liver International. 37(12). 1796–1804. 29 indexed citations

Younossi, Zobair M., Maria Stepanova, Linda Henry, et al.. (2017). A disease‐specific quality of life instrument for non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis: CLDQ‐NAFLD. Liver International. 37(8). 1209–1218. 76 indexed citations

Younossi, Zobair M., et al.. (2017). Health utilities using SF-6D scores in Japanese patients with chronic hepatitis C treated with sofosbuvir-based regimens in clinical trials. Health and Quality of Life Outcomes. 15(1). 25–25. 17 indexed citations

Younossi, Zobair M., Maria Stepanova, Linda Henry, et al.. (2016). Association of work productivity with clinical and patient‐reported factors in patients infected with hepatitis C virus. Journal of Viral Hepatitis. 23(8). 623–630. 30 indexed citations

Younossi, Zobair M., Maria Stepanova, Masao Omata, et al.. (2016). FATIGUE IN JAPANESE PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH LEDIPASVIR AND SOFOSBUVIR WITH OR WITHOUT RIBAVIRIN. Value in Health. 19(3). A316–A317. 3 indexed citations

10.

Younossi, Zobair M., Maria Stepanova, Fatema Nader, Brian Lam, & Sharon Hunt. (2015). The patient's journey with chronic hepatitis C from interferon plus ribavirin to interferon‐ and ribavirin‐free regimens: a study of health‐related quality of life. Alimentary Pharmacology & Therapeutics. 42(3). 286–295. 82 indexed citations

11.

Younossi, Zobair M., Maria Stepanova, Stefan Zeuzem, et al.. (2014). Patient-reported outcomes assessment in chronic hepatitis C treated with sofosbuvir and ribavirin: The VALENCE study. Journal of Hepatology. 61(2). 228–234. 86 indexed citations

12.

Ad, Niv, Linda Henry, Sharon Hunt, & Sari D. Holmes. (2013). Should surgical ablation for atrial fibrillation be performed in patients with a significantly enlarged left atrium?. Journal of Thoracic and Cardiovascular Surgery. 147(1). 236–241. 14 indexed citations

13.

Younossi, Zobair M., Maria Stepanova, Linda Henry, et al.. (2013). Effects of Sofosbuvir-Based Treatment, With and Without Interferon, on Outcome and Productivity of Patients With Chronic Hepatitis C. Clinical Gastroenterology and Hepatology. 12(8). 1349–1359.e13. 81 indexed citations

14.

Ad, Niv, Linda Henry, Sharon Hunt, & Sari D. Holmes. (2012). Do we increase the operative risk by adding the Cox Maze III procedure to aortic valve replacement and coronary artery bypass surgery?. Journal of Thoracic and Cardiovascular Surgery. 143(4). 936–944. 58 indexed citations

15.

Sarin, Eric L., Alan M. Speir, Linda Henry, et al.. (2012). ACUTE NORMOVOLEMIC HEMODILUTION DECREASES BLOOD PRODUCT USE AND POSTOPERATIVE MORTALITY AND MORBIDITY FOLLOWING CARDIAC SURGERY. Journal of the American College of Cardiology. 59(13). E1843–E1843. 4 indexed citations

16.

Henry, Linda, et al.. (2011). Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: A prospective randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery. 143(2). 318–325. 85 indexed citations

17.

Henry, Linda, Linda Halpin, Sari D. Holmes, Sharon Hunt, & Niv Ad. (2010). Ventilator-Associated Pneumonia Among Cardiac Surgery Patients: What More Can We Do for Prevention?. CHEST Journal. 138(4). 579A–579A. 1 indexed citations

18.

Ad, Niv, et al.. (2010). The implementation of a comprehensive clinical protocol improves long-term success after surgical treatment of atrial fibrillation. Journal of Thoracic and Cardiovascular Surgery. 139(5). 1146–1152. 25 indexed citations

19.

Martin, Lisa M., Linda Halpin, Scott D. Barnett, et al.. (2008). The Association Between Early Outcome, Health-Related Quality of Life, and Survival Following Elective Open-Heart Surgery. The Journal of Cardiovascular Nursing. 23(5). 432–442. 3 indexed citations

20.

Hunt, Sharon, et al.. (1983). A Planning Model for Public Recreation Agencies. Journal of Park and Recreation Administration. 1(2). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact